Author

George Philip 1

1 Merck & Co., Inc.,Upper Gwnedd,United States

AN OPEN LABEL PROSPECTIVE STUDY OF THESOLUBLE SERUM MARKER ST2 (IL-33 RECEPTOR) IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS TREATED WITH GOLIMUMAB: CLINICAL, ENDOSCOPIC AND HISTOLOGICAL RESULTS OF THE EVOLUTION STUDY

Fernando Jose Magro Dias, Susana Lopes, Marco Silva, Francisco Portela, Diogo Branquinho, Luis Correia, Samuel Fernandes, Marilia Lopes Cravo, Paulo Caldeira, Maria Helena Tavares Sousa, Marta Patita, Isabelle Cremers, Joana Afonso, Isabel Redondo, Patricia Machado, George Philip, Joanne Lopes, Fatima Carneiro

CALPROTECTIN IS LESS ACCURATE THAN MAYO ENDOSCOPY SCORE TO MONITOR CONTINUOUS CLINICAL RESPONSE IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

Walter Reinisch, Jean-Frederic Colombel, Ahmed Khalifa, Ruji Yao, Susan Huyck, George Philip, Freddy Cornillie

EARLY CHANGE OF PATIENT-REPORTED RECTAL BLEEDING AND STOOL FREQUENCY SCORE AND FECAL CALPROTECTIN LEVEL ARE ASSOCIATED WITH COLECTOMY OUTCOME AT 1 YEAR IN PURSUIT-MAINTENANCE TRIAL

Freddy Cornillie, Ahmed Khalifa, George Philip, Laurent Peyrin-Biroulet

EARLY DOSE OPTIMIZATION IN NONRESPONDERS TO GOLIMUMAB INDUCTION TREATMENT FOR ULCERATIVE COLITIS IS SUPPORTED BY PHARMACOKINETIC DATA THROUGH 1 YEAR

George Philip, Colleen W. Marano, Omoniyi J. Adedokun, Richard Melsheimer, Freddy Cornillie

FIVE-YEAR SAFETY DATA FROM THE OBSERVATIONAL POSTMARKETING ULCERATIVE COLITIS STUDY, A EUROPEAN REGISTRY FOR ADULTS WITH ULCERATIVE COLITIS TREATED WITH ORIGINATOR INFLIXIMAB OR STANDARD THERAPY

Julian Panés, James Lindsay, Niels Teich, Stefan Lindgren, Jean-Frederic Colombel, Freddy Cornillie, Heather Ann Flynn, Susan Huyck, Paul Stryszak, Ruji Yao, George Philip, Walter Reinisch

LACK OF EARLY RESPONSE AND MUCOSAL HEALING IS ASSOCIATED WITH COLECTOMY IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS TREATED WITH GOLIMUMAB IN THE PURSUIT-M TRIAL

Jean-Frederic Colombel, Colleen W. Marano, George Philip, Susan Huyck, Ruji Yao, Freddy Cornillie

PRIMARY STUDY RESULTS FROM GO OBSERVE: A REAL-WORLD EUROPEAN PROSPECTIVE SINGLE-ARM OBSERVATIONAL COHORT STUDY OF PATIENT-REPORTED CONTINUOUS CLINICAL RESPONSE TO GOLIMUMAB IN ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Marc Ferrante, Anja Schirbel, Marieke J. Pierik, Thomas Haas, Mathurin Flamant, Tony Terzis, Ahmed Khalifa, George Philip, Freddy Cornillie, Alan Meehan, Marinella Govoni

Item 1 - 7 / 7
1